Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
NEW YORK Health insurer Cigna will stop covering GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, in its employee health plan effective July 1, according to materials viewed by Reuters
Studies show that patients can achieve an average weight loss of 15% with semaglutide, highlighting the importance of following these steps carefully
doi: 10.2337/dc12-2454 217 ReuschJStewartMWPerkinsCMCirkelDTYeJPerryCRet al
(accessed June 2022) 15Type 2 diabetes in adults: management
US$ 25.29
US$ 28.03
US$ 26.25
US$ 26.68
US$ 29.86
US$ 26.38
